CAS 1404456-53-6
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 produits concernés.
2-Thiophenecarboxamide, 5-[[(5-chloro-2-methyl-3-pyridinyl)amino]methyl]-N-[(1S)-1-(cyclopentylmethyl)-2-(cyclopropylamino)-2-oxoethyl]-
CAS :Formule :C23H29ClN4O2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :461.0200(S)-5-(((5-Chloro-2-Methylpyridin-3-Yl)Amino)Methyl)-N-(3-Cyclopentyl-1-(Cyclopropylamino)-1-Oxopropan-2-Yl)Thiophene-2-Carboxamide
CAS :(S)-5-(((5-Chloro-2-Methylpyridin-3-Yl)Amino)Methyl)-N-(3-Cyclopentyl-1-(Cyclopropylamino)-1-Oxopropan-2-Yl)Thiophene-2-CarboxamideDegré de pureté :98%Masse moléculaire :461.02g/molGSK 2830371
CAS :GSK 2830371 is an orally active, allosteric Wip1 phosphatase inhibitor with IC50 of 6 nM.Formule :C23H29ClN4O2SDegré de pureté :99.85%Couleur et forme :SolidMasse moléculaire :461.02GSK 2830371
CAS :Produit contrôléFormule :C23H29ClN4O2SCouleur et forme :NeatMasse moléculaire :461.02GSK 2830371-d4
CAS :<p>GSK 2830371-d4 is a chemical compound that inhibits the growth of breast cancer cells. It has been shown to inhibit the proliferation of Her2+ breast cancer cells and induce apoptosis, which leads to long-term efficacy in inhibiting tumor growth. GSK 2830371-d4 also inhibits the activation of HER2+ breast cancer cells by suppressing the mitochondrial membrane potential, thereby inhibiting cell proliferation. This drug is also effective against carcinoma cell lines and shows no acute toxicities at low doses. GSK 2830371-d4 may be a potential biomarker for identifying patients with increased risk of developing breast cancer due to its ability to inhibit the activation of HER2+ breast cancer cells by suppressing the mitochondrial membrane potential.</p>Formule :C23H25D4ClN4O2SDegré de pureté :Min. 95%Masse moléculaire :465.04 g/mol
![2-Thiophenecarboxamide, 5-[[(5-chloro-2-methyl-3-pyridinyl)amino]methyl]-N-[(1S)-1-(cyclopentylmet…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA001CFZ.jpg&w=3840&q=75)
